These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17005816)

  • 1. Mycobacterium leprae is naturally resistant to PA-824.
    Manjunatha UH; Lahiri R; Randhawa B; Dowd CS; Krahenbuhl JL; Barry CE
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3350-4. PubMed ID: 17005816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of rifabutin against Mycobacterium leprae in armadillos.
    Dhople AM; Williams SL
    Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
    Dhople AM; Namba K
    Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
    Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in leprosy.
    Matsuoka M
    Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitazoxanide is active against Mycobacterium leprae.
    Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T
    PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae.
    Randhawa B; Harris EB; Prabhakaran K
    J Antimicrob Chemother; 1999 Aug; 44(2):279-81. PubMed ID: 10473236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of leprosy in multibacillary nude mice.
    Hastings RC; Chehl SK
    Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.
    Davis GL; Ray NA; Lahiri R; Gillis TP; Krahenbuhl JL; Williams DL; Adams LB
    PLoS Negl Trop Dis; 2013; 7(8):e2404. PubMed ID: 24179562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins increase rifampin mycobactericidal effect.
    Lobato LS; Rosa PS; Ferreira Jda S; Neumann Ada S; da Silva MG; do Nascimento DC; Soares CT; Pedrini SC; Oliveira DS; Monteiro CP; Pereira GM; Ribeiro-Alves M; Hacker MA; Moraes MO; Pessolani MC; Duarte RS; Lara FA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5766-74. PubMed ID: 25049257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
    Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
    J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 19. Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice.
    Ji B; Chauffour A; Andries K; Jarlier V
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1558-60. PubMed ID: 16569884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.